Review article · 2025 · Open access

Extensive Review of Nanomedicine Strategies Targeting the Tumor Microenvironment in PDAC

Xing Liu, Yidan Shao, Yunjiang Li, Zuhua Chen, Tingting Shi, Qiao Tong, Xi Zou, Liping Ju, Jinming Pan, Rangxiao Zhuang, Xuwang Pan

International Journal of Nanomedicine, Volume 20, 3379–3406 · Published 1 March 2025 · DOI 10.2147/ijn.s504503

Open full textCite this paper

In brief

“Extensive Review of Nanomedicine Strategies Targeting the Tumor Microenvironment in PDAC” is a 2025 review article by Xing Liu and 10 co-authors, published in International Journal of Nanomedicine. OpenAlex counts 28 citations as of 21 November 2026, which puts it in the top 1% of works published in 2025 by citations. It is open access under a CC BY-NC licence: the full text is free to read at International Journal of Nanomedicine.

Citations
28
Most cited in
2026 (18)
Field-weighted impact
1.20
References
149
Authors
11

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers in the world, mainly because of its powerful pro-connective tissue proliferation matrix and immunosuppressive tumor microenvironment (TME), which promote tumor progression and metastasis. In addition, the extracellular matrix leads to vascular collapse, increased interstitial fluid pressure, and obstruction of lymphatic return, thereby hindering effective drug delivery, deep penetration, and immune cell infiltration. Therefore, reshaping the TME to enhance tumor perfusion, increase deep drug penetration, and reverse immune suppression has become a key therapeutic strategy. Traditional therapies for PDAC, including surgery, radiation, and chemotherapy, face significant limitations. Surgery is challenging due to tumor location and growth, while chemotherapy and radiation are hindered by the dense extracellular matrix and immunosuppressive TME. In recent years, the advancement of nanotechnology has provided new opportunities to improve drug efficacy. Nanoscale drug delivery systems (NDDSs) provide several advantages, including improved drug stability in vivo, enhanced tumor penetration, and reduced systemic toxicity. However, the clinical translation of nanotechnology in PDAC therapy faces several challenges. These include the need for precise targeting and control over drug release, potential immune responses to the nanocarriers, and the scalability and cost-effectiveness of production. This article provides an overview of the latest nanobased methods for achieving better therapeutic outcomes and overcoming drug resistance. We pay special attention to TME-targeted therapy in the context of PDAC, discuss the advantages and limitations of current strategies, and emphasize promising new developments. By emphasizing the enormous potential of NDDSs in improving the treatment outcomes of patients with PDAC, while critically discussing the limitations of traditional therapies and the challenges faced by nanotechnology in achieving clinical breakthroughs, our review paves the way for future research in this rapidly developing field.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Liu, X., Shao, Y., Li, Y., Chen, Z., Shi, T., Tong, Q., Zou, X., Ju, L., Pan, J., Zhuang, R., & Pan, X. (2025). Extensive Review of Nanomedicine Strategies Targeting the Tumor Microenvironment in PDAC. International Journal of Nanomedicine, Volume 20, 3379–3406. https://doi.org/10.2147/ijn.s504503

MLA 9

Liu, Xing, et al. “Extensive Review of Nanomedicine Strategies Targeting the Tumor Microenvironment in PDAC.” International Journal of Nanomedicine, vol. Volume 20, 2025, pp. 3379–3406. https://doi.org/10.2147/ijn.s504503.

Chicago

Liu, Xing, Yidan Shao, Yunjiang Li, Zuhua Chen, Tingting Shi, Qiao Tong, Xi Zou, et al. 2025. “Extensive Review of Nanomedicine Strategies Targeting the Tumor Microenvironment in PDAC.” International Journal of Nanomedicine Volume 20: 3379–3406. https://doi.org/10.2147/ijn.s504503.

Harvard

Liu, X. et al. (2025) ‘Extensive Review of Nanomedicine Strategies Targeting the Tumor Microenvironment in PDAC’, International Journal of Nanomedicine, Volume 20, pp. 3379–3406. doi:10.2147/ijn.s504503.

IEEE

X. Liu et al., “Extensive Review of Nanomedicine Strategies Targeting the Tumor Microenvironment in PDAC,” International Journal of Nanomedicine, vol. Volume 20, pp. 3379–3406, 2025, doi: 10.2147/ijn.s504503.

BibTeX

@article{liu2025extensive,
  title     = {{Extensive Review of Nanomedicine Strategies Targeting the Tumor Microenvironment in PDAC}},
  author    = {Liu, Xing and Shao, Yidan and Li, Yunjiang and Chen, Zuhua and Shi, Tingting and Tong, Qiao and Zou, Xi and Ju, Liping and Pan, Jinming and Zhuang, Rangxiao and Pan, Xuwang},
  journal   = {International Journal of Nanomedicine},
  year      = {2025},
  volume    = {Volume 20},
  pages     = {3379--3406},
  doi       = {10.2147/ijn.s504503},
  url       = {https://doi.org/10.2147/ijn.s504503}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery

  • pancreatic ductal adenocarcinoma
  • tumor microenvironment
  • nanomedicine
  • nanoscale drug delivery systems
  • extracellular matrix
  • immunosuppression
  • tumor perfusion
  • drug resistance

Work with this paper

Most-cited papers in Materials Science

All highly cited Materials Science papers

Questions about this paper

How do I cite this paper in APA style?

Liu, X., Shao, Y., Li, Y., Chen, Z., Shi, T., Tong, Q., Zou, X., Ju, L., Pan, J., Zhuang, R., & Pan, X. (2025). Extensive Review of Nanomedicine Strategies Targeting the Tumor Microenvironment in PDAC. International Journal of Nanomedicine, Volume 20, 3379–3406. https://doi.org/10.2147/ijn.s504503

How many times has this paper been cited?

28 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at International Journal of Nanomedicine: sign in and open the full text from this page.

Who wrote this paper?

Xing Liu, Yidan Shao, Yunjiang Li, Zuhua Chen, Tingting Shi, Qiao Tong, Xi Zou, Liping Ju, Jinming Pan, Rangxiao Zhuang, Xuwang Pan.

What is the DOI of this paper?

10.2147/ijn.s504503, permanently at https://doi.org/10.2147/ijn.s504503. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.